Natera, Inc. Profile Avatar - Palmy Investing

Natera, Inc.

Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as tw…

Medical - Diagnostics & Research
US, San Carlos [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group

Peer Group Analysis

A quick analysis that compared Natera, Inc. (NTRA) to it's peer group, including competitors as well as it's industry. All monetary values in mil. except volume - volume is in thousands.

Company Price Change Volume, Avg. Market Cap. Revenue Profit Net Earnings Free Cash Flow Dividend Yield P/E EPS Gross Margin % Net Margin % ROE % ROA % Quick Ratio % Shares Outstanding
Diagnostics & Research Average - - - - - - 51,893.45 5,186.10 229.85 9,497.16 51.76 0.00 -3.4126 46.48 0.4078 -0.0622 0.00 0.05 1.8581 - -
Maximum - - - - - - 916,755.00 59,467.00 2,293.00 94,270.00 922.00 0.03 193.1841 880.40 1.0000 0.2192 0.06 0.58 5.1261 - -
Minimum - - - - - - 0.00 0.00 -31.00 -2,079.00 -981.00 0.00 -515.5998 -1.93 -0.1974 -2.1105 -0.28 -0.07 0.0000 - -
Exact Sciences Corporation EXAS 55.36 -1.32 -2.33% 614 vs. 2,381 10,245.00 - - - - - - - - - - - - - - - - - - - - - - - - 185.00
Guardant Health, Inc. GH 36.39 -0.20 -0.55% 966 vs. 1,817 4,496.00 - - - - - - - - - - - - - - - - - - - - - - - - 123.00
Illumina, Inc. ILMN 135.64 -4.04 -2.89% 376 vs. 1,979 21,512.00 - - - - - - - - - - - - - - - - - - - - - - - - 158.00
NeoGenomics, Inc. NEO 15.30 -3.31 -17.79% 920 vs. 718 1,963.00 - - - - - - - - - - - - - - - - - - - - - - - - 128.00
Neogen Corporation NEOG 12.09 -0.98 -7.50% 2,702 vs. 1,770 2,619.00 - - - - - - - - - - - - - - - - - - - - - - - - 216.00
Natera, Inc. NTRA 172.87 -3.74 -2.12% 657 vs. 1,218 22,822.00 - - - - - - - - - - - - - - - - - - - - - - - - 132.00
Qiagen N.V. QGEN 45.05 -0.21 -0.45% 323 vs. 857 9,995.00 - - - - - - - - - - - - - - - - - - - - - - - - 221.00
More Due Diligence
Compare Fundamentals
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.
Watchlist
Keep an eye one one or all of the stocks by building a new watchlist.
Intrinsic Values
Utilize our versatile Gordan Growth Model for NTRA and its peers to uncover potential buy and sell opportunities.
End of NTRA's Analysis
CIK: 1604821 CUSIP: 632307104 ISIN: US6323071042 LEI: - UEI: -
Secondary Listings
NTRA has no secondary listings inside our databases.